Aclaris Therapeutics Inc (NASDAQ:ACRS) shares, rose in value on Thursday, May 08, with the stock price up by 4.80% to the previous day’s close as strong demand from buyers drove the stock to $1.31. Actively observing the price movement in the last trading, the stock
Aclaris Therapeutics Inc (NASDAQ:ACRS) shares, rose in value, with the stock price up by 0.78% to the previous day’s close as strong demand from buyers drove the stock to $1.26. Actively observing the price movement in the recent trading, the stock is buoying the session
Aclaris Therapeutics Inc (NASDAQ:ACRS) concluded the trading at $1.27 on current market day with a rise of 6.72% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.19 and 5Y monthly beta
Aclaris Therapeutics Inc (NASDAQ:ACRS) traded at $1.17 at last check on current trade day and made an upward move of 3.54% on its previous day’s price. Looking at the stock we see that its previous close was $1.13 and the beta (5Y monthly) reads 0.542
The trading price of Aclaris Therapeutics Inc (NASDAQ:ACRS) closed higher on Friday, April 11, and closing at $1.15, 6.48% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.09 and $1.17. In examining the
Aclaris Therapeutics Inc (NASDAQ:ACRS) price on current trading day, fall -1.63% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.21. A look at the stock’s price movement, the close in the last trading session was $1.23, moving
The trading price of Aclaris Therapeutics Inc (NASDAQ:ACRS) closed higher on current market day and closing at $1.70, 6.25% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.59 and $1.755. In examining the
Aclaris Therapeutics Inc (NASDAQ:ACRS) price closed on Tuesday, March 18, and remained unchanged from its previous close. A look at the daily price movement shows that the last close reads $1.58, with intraday deals fluctuated between $1.55 and $1.62. The company’s 5Y monthly beta was
Aclaris Therapeutics Inc (NASDAQ:ACRS) concluded the trading at $1.56 on Thursday, March 13 with a fall of -1.89% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.59 and 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
